Systemic Immune Checkpoint Inhibitors: Successful Treatment of Conjunctival Atypical Melanocytic Proliferation Documented by Anterior Segment Optical Coherence Tomography

Journal article

Peer reviewed

Gelila B Yohannes, Nathan L Scott, Wendy J Li and Carol L Karp

The ocular surface

2025-07-19

PMID: 40692094

Abstract

nivolumab

cutaneous malignant melanoma

ipilimumab

primary acquired melanosis

anti-PDL1

immune checkpoint inhibitors

anti-PD1

conjunctival melanocytic proliferation

conjunctival melanoma

4 Record Views

Title: Systemic Immune Checkpoint Inhibitors: Successful Treatment of Conjunctival Atypical Melanocytic Proliferation Documented by Anterior Segment Optical Coherence Tomography
Creators: Gelila B Yohannes - University of Miami
Nathan L Scott - University of Miami
Wendy J Li - Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Carol L Karp - University of Miami
Publication Details: The ocular surface
Academic Unit: UMMG Department of Ophthalmology; Miller School of Medicine
Language: English
Resource Type: Journal article
PMID: 40692094
Record Identifier: 991032731810102976